UNSPSC 51143006: Choline alfoscerate

This classification denotes a glycerylphosphorylcholine with the molecular formula C8H20NO6P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 60M22SGW66, chemically known as ethanaminium, 2-(((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)-n,n,n-trimethyl-, hydroxide, inner salt, (r)- but generally known as choline alfoscerate, which bears US NIH Compound Identifier 71920. European Medicines Agency schedules Choline alfoscerate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06216MIG.

UNSPSC 51143006 Choline alfoscerate, a Commodity code, addresses a specialized pharmaceutical ingredient with minimal recent state and local procurement activity. The code covers choline alfoscerate, a pharmaceutical compound used in medical formulations, but state and local governments rarely solicit this ingredient directly as a standalone procurement. When purchased, it typically appears as a component in larger pharmaceutical supply contracts or medical formulation work managed through healthcare systems, state pharmacy benefit programs, or institutional medical procurement offices.

The source provides no recent state and local contract opportunities under this code. Given the specialized nature of choline alfoscerate and the typical procurement pathways for pharmaceutical ingredients — which flow through state health department contracts, hospital systems, and group purchasing organizations rather than direct public solicitation — activity under this Commodity code remains dormant in the recent state and local marketplace. Firms pursuing pharmaceutical ingredient supply should monitor broader pharmaceutical and medical supply family and class codes where state and local healthcare entities consolidate ingredient sourcing, rather than expect standalone solicitations under this narrow Commodity designation.